Prevalence and effect on survival of pre-treatment sarcopenia in patients with hematological malignancies: a meta-analysis

Background & aimsEvidence regarding the prevalence of pre-treatment sarcopenia and its impact on survival in patients with hematological malignancies (HM) varies across studies. We conducted a systematic review and meta-analysis to summarize this discrepancy.MethodsPubMed, Embase and Cochrane library were systematically searched for relevant studies. Outcomes assessed were: prevalence of pre-treatment sarcopenia, overall survival (OS), progression-free survival (PFS) and complete response (CR). Weighted mean proportion, odds ratios (ORs) and hazard ratios (HRs) were estimated using a fixed-effects and a random-effects model.ResultsA total of 27 retrospective cohort studies involving 4,991 patients were included in this study. The prevalence of pre-treatment sarcopenia was 37.0% (95% CI: 32.0%-42.0%) in HM patients <60 years and 51.0% (95% CI: 45.0%-57.0%) in≥60 years. Patients with leukemia had the lowest prevalence, compared with those with other HM (38.0%; 95% CI: 33.0%-43.0%; P = 0.010). The presence of sarcopenia was independently associated with poor OS (HR = 1.57, 95% CI = 1.41-1.75) and PFS (HR = 1.50, 95% CI = 1.22-1.83) throughout treatment period, which may be partially attributed to decreased CR (OR = 0.54, 95% CI = 0.41-0.72), particularly for BMI ≥ 25 (P = 0.020) and males (P = 0.020).ConclusionSarcopenia is highly prevalent in patients with HM and an adverse prognostic factor for both survival and treatment efficacy. HM and sarcopenia can aggravate each other. We suggest that in future clinical work, incorporating sarcopenia into risk scores will contribute to guide patient stratification and therapeutic strategy, particularly for the elderly.Systematic review registrationhttps://www.crd.york.ac.uk/prospero/, identifier (CRD42023392550)

Inhibition of Phosphodiesterase-4 Reverses Aβ-Induced Memory Impairment by Regulation of HPA Axis Related cAMP Signaling

Beta amyloid peptides (Aβ) are found to be associated with dysfunction of hypothalamic-pituitary-adrenal axis (HPA axis) that leads to memory and cognitive deficits in patients with Alzheimer’s disease (AD). Phosphodiesterase 4 (PDE4) inhibitors increase the intracellular cAMP activities, which may ameliorate cognitive deficits associated with AD. However, it remains unclear whether PDE4-mediated reversal of cognitive impairment in mouse model of AD is related to HPA axis and downstream cAMP-dependent pathway. The present study investigated the effects of PDE4 inhibitor rolipram on Aβ1-42-induced cognitive dysfunction and its underlying mechanisms. The step-down passive avoidance (PA) and Morris water-maze (MWM) tests were conducted 1 week (1 W), 2 months (2 M), and 6 months (6 M) after intracerebroventricular microjection (i.c.v.) of Aβ1-42. The results suggested that memory impairment emerged as early as 1 W, peaked at 2 M, and lasted until 6 M after injection. Chronic treatment with rolipram (0.1, 0.5, 1.0 mg/kg/d, i.p.) for 2 weeks (i.e., treatment started at 1.5 months after Aβ1-42 microinjection) dose-dependently improved memory performance in both MWM and PA tests. Moreover, rolipram reversed the Aβ-induced increases in serum corticosterone (CORT), corticotropin-releasing factor, and glucocorticoid receptors (CRF-R and GR) levels, whereas it decreases in brain-derived neurotropic factor (BDNF) and the ratio of pCREB to CREB expression. These effects of rolipram were prevented by pre-treatment with PKA inhibitor H89. The findings indicated that the protective effects of rolipram against Aβ1-42-induced memory deficits might involve HPA axis and cAMP-CREB-BDNF signaling

Investigation on the Ductility Capacity of Concrete Columns with High Strength Steel Reinforcement under Eccentric Loading

Ductility-based structural design is currently the mainstream method. In order to analyze the ductility performance of concrete columns with high-strength steel reinforcements under eccentric compression, corresponding experimental studies have been performed. Numerical models were established, and their reliability was verified. Based on the numerical models, the parameter analysis was carried out, where eccentricity, concrete strength, and reinforcement ratio were considered to systematically discuss the ductility of the concrete column section with high-strength steel reinforcement. The results show that the ductility of the section under eccentric compression increases with the strength of the concrete and eccentricity, and decreases with the reinforcement ratio. Finally, a simplified calculation formula capable of quantitatively evaluating the section ductility was proposed

In Vitro Effects on Thrombin of Paris Saponins and In Vivo Hemostatic Activity Evaluation of Paris fargesii var. brevipetala

The resource shortage of Rhizoma Paridis has never been effectively addressed, and the industry continues to search for alternative resources. The in vitro effects on thrombin of Paris saponins and in vivo hemostatic activity of Paris fargesii var. brevipetala (PF) were evaluated in this study. PF is considered to be an alternative source of Rhizoma Paridis (RP). The in vitro incubation experiment was designed to investigate the effects on thrombin activity of Paris saponin H (PS H) and saponin extract in PF. The bleeding time of mouse tail snipping was used to evaluate the in vivo hemostatic effects of Paris saponins. Also, in vivo changes in four blood coagulation parameters in rats after oral administration of different groups of Paris saponins were compared. The effects of Paris saponins on liver function and blood lipid parameters were examined in order to avoid drug-induced liver injury. Activity studies of thrombin after ultra-filtration centrifugation showed that Paris saponins were able to enhance thrombin activity. Ultra performance liquid chromatography mass spectrometry (UPLC-MS) analysis results of the substrates led us to speculate that there is a specific binding between Paris saponins and thrombin. PS H and Paris saponins in PF significantly shortened the bleeding time in mice. One pathway by which Paris saponins enhance in vivo blood coagulation is by increasing fibrinogen (FIB), among the four blood coagulation parameters in rats. At the same time, the effects on liver and blood lipid parameters were insignificant. P. fargesii var. brevipetala can be developed as an alternative medicinal source of Rhizoma Paridis

Metallic porous iron nitride and tantalum nitride single crystals with enhanced electrocatalysis performance

Altering a material's catalytic properties would require identifying structural features that deliver electrochemically active surfaces. Single-crystalline porous materials, combining the advantages of long-range ordering of bulk crystals and large surface areas of porous materials, would create sufficient active surfaces by stabilizing 2D active moieties confined in lattice and may provide an alternative way to create high-energy surfaces for electrocatalysis that are kinetically trapped. Here, a radical concept of building active metal–nitrogen moieties with unsaturated nitrogen coordination on a porous surface by directly growing metallic porous metal nitride (Fe3N and Ta5N6) single crystals at unprecedented 2 cm scale is reported. These porous single crystals demonstrate exceptionally high conductivity of 0.1–1.0 × 105 S cm−1, while the atomic surface layers of the porous crystals are confirmed to be an Fe termination layer for Fe3N and a Ta termination layer for Ta5N6. The unsaturated metal–nitrogen moieties (Fe6–N and Ta5–N3) with unique electronic structures demonstrate enhanced electrocatalysis performance and durability

Origins of natural gas and the main controlling factors of gas accumulation in the Middle Ordovician assemblages in Jingxi area, Ordos Basin

During the progressive exploration of the Jingbian Gas Field in the Ordos Basin, multiple gas-bearing regions have been discovered in the dolomite reservoirs in the Middle Ordovician assemblages of Lower Paleozoic in Jingxi area, but these gas-bearing regions and intervals are significantly different in terms of gas enrichment degrees. So far, however, the reasons for the difference have not been figured out. In this paper, the origin and source of natural gas in the Middle Ordovician assemblages in Jingxi area was investigated on the basis of geochemical data (e.g. natural gas composition and carbon isotope), and then the main factors controlling the gas accumulation were analyzed. It is shown that the natural gas in the Middle Ordovician assemblages in the Middle Ordovician assemblages in Jingxi area is similar to that in the Upper Ordovician assemblages and Upper Paleozoic reservoir in terms of genesis and sources, and they are mainly the Upper Paleozoic coaliferous gas with some oil-derived gas. Under the influence of hydrocarbon generation center of coal source rocks and the source–rock–reservoir contact relationship, the proportion of coaliferous gas increases areally from the north to the south and vertically from Ma55 sub-member of the Lower Ordovician Majiagou Fm. It is concluded that the natural gas enrichment degree is controlled by the gas charging capacity at the hydrocarbon-supplying windows. Second, the vertical migration and distribution of natural gas is dominated by the differences of Ma55−Ma510 transport pathways. And third, the lateral migration direction of natural gas and the range of gas accumulation are controlled by the superimposition relationship between structures and reservoirs

A Composite Whole-Biomass Tannin–Sucrose–Soy Protein Wood Adhesive with High Performance

Whole-biomass adhesives are the research hotspot of wood adhesives andcan improve the competitiveness of adhesives. The tannin–sucrose adhesive studied by our research group shows good bonding performance, but poor bonding stability induced by low viscosity. In this study, the tannin–sucrose adhesive was modified by isolated soybean protein (SPI), the effect of the SPI substitution ratio for tannin on the properties of the tannin–sucrose–SPI composite adhesive was investigated, and the bonding mechanism was explored using Fourier-transform infrared spectroscopy (FT-IR), thermogravimetry (TG), X-ray diffraction (XRD), and gas chromatography–mass spectroscopy (GC–MS). The results showed that: (1) when the SPI substitution ratio was above 40%, the viscosity of the composite adhesive increased significantly, which effectively avoided adhesive leakage. (2) The tannin–sucrose–SPI composite adhesive displayed high bonding performance and water resistance. (3) The FTIR and GC–MS results revealed that the curing mechanism of the tannin–sucrose–SPI adhesive was very complicated, but it was certain that the conversion of sucrose into furan compounds, especially 5-hydroxymethylfurfural (5-HMF), was the core of the cross-linking reaction of the adhesive when elevating temperature. (4) The macromolecules and high reactivity of SPI compensated for the shortage of high temperature required for the conversion of sucrose into furanic cross-linkers so that the tannin–sucrose–SPI adhesive experienced an efficient curing reaction at a low temperature, and the reaction degree and thermal stability of the curing product increased

In Silico Identification and Validation of Cuproptosis-Related LncRNA Signature as a Novel Prognostic Model and Immune Function Analysis in Colon Adenocarcinoma

Background: Colon adenocarcinoma (COAD) is the most common subtype of colon cancer, and cuproptosis is a recently newly defined form of cell death that plays an important role in the development of several malignant cancers. However, studies of cuproptosis-related lncRNAs (CRLs) involved in regulating colon adenocarcinoma are limited. The purpose of this study is to develop a new prognostic CRLs signature of colon adenocarcinoma and explore its underlying biological mechanism. Methods: In this study, we downloaded RNA-seq profiles, clinical data and tumor mutational burden (TMB) data from the TCGA database, identified cuproptosis-associated lncRNAs using univariate Cox, lasso regression analysis and multivariate Cox analysis, and constructed a prognostic model with risk score based on these lncRNAs. COAD patients were divided into high- and low-risk subgroups based on the risk score. Cox regression was also used to test whether they were independent prognostic factors. The accuracy of this prognostic model was further validated by receiver operating characteristic curve (ROC), C-index and Nomogram. In addition, the lncRNA/miRNA/mRNA competing endogenous RNA (ceRNA) network and protein–protein interaction (PPI) network were constructed based on the weighted gene co-expression network analysis (WGCNA). Results: We constructed a prognostic model based on 15 cuproptosis-associated lncRNAs. The validation results showed that the risk score of the model (HR = 1.003, 95% CI = 1.001–1.004; p < 0.001) could serve as an independent prognostic factor with accurate and credible predictive power. The risk score had the highest AUC (0.793) among various factors such as risk score, stage, gender and age, also indicating that the model we constructed to predict patient survival was better than other clinical characteristics. Meanwhile, the possible biological mechanisms of colon adenocarcinoma were explored based on the lncRNA/miRNA/mRNA ceRNA network and PPI network constructed by WGCNA. Conclusion: The prognostic model based on 15 cuproptosis-related lncRNAs has accurate and reliable predictive power to effectively predict clinical outcomes in colon adenocarcinoma patients

Table_1_Prevalence and effect on survival of pre-treatment sarcopenia in patients with hematological malignancies: a meta-analysis.doc

Background & aimsEvidence regarding the prevalence of pre-treatment sarcopenia and its impact on survival in patients with hematological malignancies (HM) varies across studies. We conducted a systematic review and meta-analysis to summarize this discrepancy.MethodsPubMed, Embase and Cochrane library were systematically searched for relevant studies. Outcomes assessed were: prevalence of pre-treatment sarcopenia, overall survival (OS), progression-free survival (PFS) and complete response (CR). Weighted mean proportion, odds ratios (ORs) and hazard ratios (HRs) were estimated using a fixed-effects and a random-effects model.ResultsA total of 27 retrospective cohort studies involving 4,991 patients were included in this study. The prevalence of pre-treatment sarcopenia was 37.0% (95% CI: 32.0%-42.0%) in HM patients ConclusionSarcopenia is highly prevalent in patients with HM and an adverse prognostic factor for both survival and treatment efficacy. HM and sarcopenia can aggravate each other. We suggest that in future clinical work, incorporating sarcopenia into risk scores will contribute to guide patient stratification and therapeutic strategy, particularly for the elderly.Systematic review registrationhttps://www.crd.york.ac.uk/prospero/, identifier (CRD42023392550).</p